News

All news

2019-10-29

ACCORD HEALTHCARE LAUNCH ALENDRONIC ACID/CHOLECALCIFEROL

Accord Healthcare is delighted to announce the launch of Alendronic acid/Cholecalciferol Accord 70 mg/2,800 IU x 4 Tablets and Alendronic acid/Cholecalciferol Accord 70 mg/5,600 IU x 4 Tablets.

This medicine is indicated for the treatment of postmenopausal osteoporosis in women at risk of vitamin D insufficiency. It reduces the risk of vertebral and hip fractures.

Please refer to the Summary of Product Characteristics (SPC) for further information. The SPC is available here or from www.hpra.ie.

All news